What the broad has failed to do: 1. Provide an indication of all the milestones required of it to receive the full $200M+ from Pfizer. 2. Provide the value and timescale of each milestone. 3. Provide a reasonable expection that they are confident that PSD will achieve each milestone. 4.Fill the vacancy on the board created by the poorly explained exit of co-founder Dr Roger Aston.
If you want an example what a board/(change) can do for a sp have a look at FMG and NIA.
PSD Price at posting:
0.0¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
